The GORE ® CARDIOFORM Septal Occluder is a permanently implanted device indicated for the percutaneous, transcatheter closure of the following defects of the atrial septum: ostium secundum atrial septal defects (ASDs); patent foramen ovale (PFO) to reduce the risk of recurrent ischemic stroke in patients, predominantly between the ages of 18 ...

Designed to perform with the natural anatomy of the heart, the GORE® CARDIOFORM Septal Occluder is a soft and conformable device for transcatheter closure of ASDs and PFOs up to 17 mm, including challenging defects.

The GORE® CARDIOFORM ASD Occluder advances ASD closure with a solution designed to naturally conform to each unique defect, delivering on a legacy of safety and performance.

ゴア® カーディオフォーム asdオクルーダーは、心臓内に恒久的に留置するデバイスであり、小児から成人の心房中隔欠損（asd）閉鎖術に使用されます。

ASSURED clinical study: new GORE® CARDIOFORM ASD Occluder for transcatheter closure of atrial septal defect. Catheterization & Cardiovascular Interventions 2020;95(7):1285-1295. GORE® CARDIOFORM ASD Occluder [Instructions for Use].

Deficient Rim GORE® CARDIOFORM ASD Occluder Product Brochure Product brochure for the GORE® CARDIOFORM ASD Occluder featuring the Deficient-Rim Campaign message. PDF, 6.65 MB

The GORE® CARDIOFORM Septal Occluder is a permanently implanted device indicated for the percutaneous, transcatheter closure of atrial septal defects (ASDs), such as ostium secundum and patent foramen ovale.

The GORE ® CARDIOFORM ASD Occluder is a permanently implanted device indicated for the percutaneous, transcatheter closure of ostium secundum atrial septal defects (ASDs).

The GORE® CARDIOFORM ASD Occluder is a permanently implanted device indicated for the percutaneous, transcatheter closure of ostium secundum atrial septal defects (ASDs).

The GORE ® CARDIOFORM ASD Occluder continues to demonstrate its well-established safety profile and clinical performance, building on more than 8 years of clinical use with 13,000+ devices sold globally for the percutaneous closure of …